Your browser doesn't support javascript.
loading
IFITM3-specific antibody reveals IFN preferences and slow IFN induction of the antiviral factor IFITM3 in humans.
Wellington, Dannielle; Yin, Zixi; Abdel-Haq, Adi; Zhang, Liwei; Forbester, Jessica; Kite, Kerry; Rajapaksa, Ushani; Laurenson-Schafer, Henry; Makvandi-Nejad, Shokouh; Jin, Boquan; Bowes, Emma; Manoharan, Krishnageetha; Maldonado-Perez, David; Verrill, Clare; Humphreys, Ian R; Dong, Tao.
Afiliação
  • Wellington D; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, Oxford University, Oxford, UK.
  • Yin Z; Nuffield Department of Medicine, Chinese Academy of Medical Sciences (CAMS) Oxford Institute, Oxford University, Oxford, UK.
  • Abdel-Haq A; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, Oxford University, Oxford, UK.
  • Zhang L; Nuffield Department of Medicine, Chinese Academy of Medical Sciences (CAMS) Oxford Institute, Oxford University, Oxford, UK.
  • Forbester J; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, Oxford University, Oxford, UK.
  • Kite K; Charles Tanford-Proteinzentrum, Martin-Luther-Universität Halle-Wittenberg, Institut für Molekulare Medizin, Kurt-Mothes-Straße 3a, Halle, Germany.
  • Rajapaksa U; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, Oxford University, Oxford, UK.
  • Laurenson-Schafer H; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, Oxford University, Oxford, UK.
  • Makvandi-Nejad S; Division of Infection and Immunity/Systems Immunity University Research Institute, Cardiff University, Cardiff, UK.
  • Jin B; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, Oxford University, Oxford, UK.
  • Bowes E; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, Oxford University, Oxford, UK.
  • Manoharan K; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, Oxford University, Oxford, UK.
  • Maldonado-Perez D; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, Oxford University, Oxford, UK.
  • Verrill C; Fourth Military Medical University, Xian, China.
  • Humphreys IR; Oxford Radcliffe Biobank, Nuffield Department of Surgical Sciences, Oxford University, Oxford, UK.
  • Dong T; Oxford Radcliffe Biobank, Nuffield Department of Surgical Sciences, Oxford University, Oxford, UK.
Eur J Immunol ; 51(3): 742-745, 2021 03.
Article em En | MEDLINE | ID: mdl-33125710
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Interferon Tipo I / Proteínas de Ligação a RNA / Proteínas de Membrana Limite: Humans Idioma: En Revista: Eur J Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Interferon Tipo I / Proteínas de Ligação a RNA / Proteínas de Membrana Limite: Humans Idioma: En Revista: Eur J Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido